ASSESSMENT OF WEIGHT AND ITS RELATIONSHIP WITH BREAST CANCER IN A CLINICAL ONCOLOGY SERVICE IN THE FEDERAL DISTRICT

Abstract

Objective: The purpose of this study was to analyze the relationship between obesity and clinical outcomes in breast
cancer patients by evaluating the mean body mass index (BMI) and overall survival. Methods: This is a retrospective
observational and descriptive study without intervention, carried out in a public oncology service in the Federal District.
We selected breast cancer patients with hormonal expression positivity in follow-up from January 2016 to December 2020.
Results: In all, 305 female patients were evaluated, aged between 33 and 92 years with a median age of 59 years. Most
patients were over 55 years of age (63.3%). The mean weight of the patients was 71.70±9.10 kg. Regarding BMI, 38.7% of
patients were classified as obese. As for the immunohistochemical (IHC) classification, 72.9% of the patients were Luminal
B. Among the patients in whom the initial treatment was registered, 56.1% received hormone therapy, while 43.9% received
chemotherapy. The intention to treat in most patients was curative. Most patients had disease staging between II and III.
As for the outcome, most patients were still undergoing treatment (83.0%) at the time of data collection. Correlating the
IHC classification with patient survival, there was no significant difference between patients classified as luminal A and
those classified as luminal B (p=0.342). There was also no significant difference between non-obese and obese patients in
the assessment of overall survival and weight (p=0.917). Conclusion: Despite the high prevalence of obesity in the studied
population, the overall survival of this group did not differ from the non-obese group, even in the analysis by IHC profile.